Back to results
US 2019/0375746 A1Published application
Benzoquinoline inhibitors of vesicular monoamine transporter 2
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manouchehr Shahbaz
Life of this patent
Estimating the term…
Abstract
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
Claims20
A compound that is
- wherein each position indicated as D has deuterium enrichment of at least 50%.
Dependencies are inferred from the claim text.